期刊文献+

不使用造影剂的腹主动脉瘤腔内隔绝术 被引量:6

Non-contrasted endovascular exclusion for abdominal aortic aneurysm
下载PDF
导出
摘要 目的 探讨一种不使用造影剂的腹主动脉瘤 (AAA)腔内隔绝术 (EVE) ,治疗合并肾功能不全的AAA患者。方法 对 3例合并肾功能不全的AAA患者在不使用造影剂条件下实施AAAEVE ,并对术前评估内容进行分析。结果  3例患者手术均获成功 ,2例采用分叉型移植物 ,1例采用直型移植物。术后随访结果表明 ,动脉瘤被完全隔绝 ,无内漏 ,瘤腔内血栓形成 ;移植物内血流通畅 ,周围无异常血流。结论 选择近端瘤颈较长的患者 ,术前对肾动脉及髂内动脉开口位置等指标进行准确评估 ,不使用造影剂同样可以完成AAAEVE。 Objective To discuss the endovascular exclusion without using contrast for abdominal aortic aneurysm patients with renal disfunction. Methods We performed endovascular exclusion for abdominal aortic aneurysm in 3 cases associated with renal disfunction. The evaluations of related diagnostic informations including images were reviewed before operation. Results The operations were successful in all 3 cases with 2 bifurcation grafts and 1 straight graft. After 1 to 3 months follow up through colour ultrasound, we found the aneurysms were excluded completely without endoleak, and occluded with thrombosis. The bloodflow in the graft was patent without abnormal peripheral circulation. Conclusions Endovascular exclusion can be successfully performed on the abdominal aortic aneurysm with long aneurysm neck. Preoperative evaluation is important for the localigation of renal artery and hypogastric artery.
出处 《介入放射学杂志》 CSCD 2003年第1期8-10,共3页 Journal of Interventional Radiology
基金 军队杰出人才基金 (98J0 0 5 ) 上海市卫生系统百人计划基金 (97BR0 47) 长海医院学科攀登计划基金资助课题
关键词 腹主动脉瘤 腔内隔绝术 造影剂 治疗 Abdominal aortic aneurysm Endovascular exclusion Contrast
  • 相关文献

参考文献5

二级参考文献18

共引文献155

同被引文献46

  • 1吉俊,丁小强,许迅辉,邹建洲,何建强,林贻梅,柏瑾,钱菊英.低渗非离子造影剂对冠状动脉介入诊疗术患者肾功能影响的前瞻性研究[J].中华肾脏病杂志,2006,22(7):388-392. 被引量:46
  • 2常光其,王深明,李晓曦,胡作军,姚陈,殷恒讳,杨建勇,陈伟,李嘉平.DeBakey Ⅰ型主动脉夹层动脉瘤的血管腔内治疗[J].中华外科杂志,2007,45(3):168-171. 被引量:20
  • 3Singh K,Bonna KH,Jacobsen BK,et al.Prevalence of and risk factors for abdominal aortic aneurysms in a population-based study [J].Stud Am J Epidemiol,2001,154(3):236-244.
  • 4Parodi JC,Palmaz JC,Barone HD,et al.Transfemoral intraluminal graft implantation for abdominal aortic aneurysms[J].Ann Vasc Surg,1991,5(6):491-9.
  • 5Kandzari DE,Rebeiz AG,et al.Contrast nephropathy:an evidence-based approach to prevention[J].Am J Cardiovasc Drugs,2003,3(6):395-405.
  • 6Takasuna K,Kasai Y,Kitano Y,et al.General pharmacological study of iodixanol,a new non-ionic isotonic contrast medium[J].J Toxicol Sci,1995,20(suppl) 1:133-51.
  • 7Fischbach R,Landwehr P,Lackner K,et al.Iodixanol vs iopamidol in intravenous DSA of the abdominal aorta and lower extremity arteries:a comparative phase-Ⅲ trial[J].Eur Radiol,1996,6(1):9-13.
  • 8Michel E,Bertrand MD,Enrique Esplugas MD,et al.Influence of a nonionic,iso-osmolar contrast medium(Iodixanol) versus an ionic,low-osmolar contrast medium (ioxaglate) on major adverse cardiac events in patients undergoing percutaneous transluminal coronary angioplasty[J].Circulation,2000,101:131.
  • 9Baumgart D,Haude M,George G,et al.High-volume nonionic dimeric contrast medium:first experiences during complex coronary interventions[J].Cathet Cardiovasc Diagn,1997,40(3):241-6.
  • 10Flinck A,Selin K,Bgorneld L,et al.Iodixanol and iohexol in cardioangiography.A comparative vectorcardiographic study[J].Acta Radiol,2000,41(4):384-9.

引证文献6

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部